Litcius/Paper detail

Predictive models for response and survival in patients treated with anti-PD-1 monotherapy or with anti-PD-1 and ipilimumab combination: editorial commentary

Anand Rotte

2023Annals of Translational Medicine32 citationsDOIOpen Access PDF

Topics & Concepts

IpilimumabMedicineOncologyInternal medicinePharmacologyImmunotherapyImmune systemImmunologyCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and StudiesImmunotherapy and Immune Responses
Predictive models for response and survival in patients treated with anti-PD-1 monotherapy or with anti-PD-1 and ipilimumab combination: editorial commentary | Litcius